Gene: RPRM
Official Full Name: reprimo, TP53 dependent G2 arrest mediator homologprovided by HGNC
Gene Summary: Predicted to be involved in regulation of mitotic cell cycle. Predicted to act upstream of or within regulation of cell cycle. Predicted to be located in membrane. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO14423 | RPRM Knockout cell line (HeLa) | Human | RPRM | 1:3~1:6 | Negative | Online Inquiry |
KO14424 | RPRM Knockout cell line (HEK293) | Human | RPRM | 1:3~1:6 | Negative | Online Inquiry |
RPRM Gene Knockout Cell Lines are genetically modified cell lines that are specifically engineered to lack the expression of the RPRM gene, which encodes the protein Repressor of Protein Phosphatase 2A (RPRM). This product is designed to facilitate advanced biological research into the role of RPRM in cellular processes, particularly in cancer biology and signal transduction pathways. By utilizing CRISPR-Cas9 technology or other cutting-edge gene-editing techniques, RPRM gene knockout cell lines provide a precise model system to study the functional consequences of the absence of RPRM, including its impact on cell proliferation, differentiation, and apoptosis.
The key function of RPRM gene knockout cell lines lies in their ability to serve as a platform for probing the biological implications of RPRM loss. This can reveal critical insights into tumorigenesis, elucidating how RPRM serves as a tumor suppressor in certain contexts. In clinical research, these cell lines are invaluable for screening potential therapeutic compounds, enabling scientists to identify drugs that can target cells with altered RPRM expression.
One of the significant advantages of RPRM gene knockout cell lines is their specificity and reproducibility in experiments, providing higher reliability compared to non-targeted approaches. As researchers aim for precision medicine, these cell lines offer a tailored approach, allowing for the study of RPRM's role across various cancer types and conditions. This targeted use enhances the potential to draw meaningful conclusions from experimental data, making it easier for researchers and clinicians to devise strategies for patient-specific therapies.
The utility of RPRM gene knockout cell lines extends beyond basic research applications; they are instrumental in advancing our understanding of cancer pathways and aiding drug discovery efforts. With a reputation for excellence in developing high-quality research tools, our company integrates years of expertise in molecular biology to offer a product that supports cutting-edge research. By choosing RPRM Gene Knockout Cell Lines, you are investing not only in a high-performance product but also in a collaborative partnership aimed at driving innovation in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.